Skip to main content

Table 1 General characteristics of the survey participants by the size of participating centers

From: Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

 

Total (73 responses)

Small centers (40 responses)

Large centers (33 responses)

p-value

Number of pediatric nephrologists per center, median [IQR]

4 [3, 8]

3 [3, 4]

8 [7, 10]

 

Number of pediatric nephrologists who were in practice for >10 years, n (%)

25 (34)

10 (25)

15 (45)

0.07

Number of patients receiving rhGH, n (%):

   

0.02a

 0

7 (9.6)

7 (17.5)

0 (0)

 1–5

44 (60.3)

20 (50.0)

24 (72.73)

  > 5

22 (30.1)

13 (32.5)

9 (27.27)

Number of patients on dialysis, median [IQR]

12 [5, 18]

5.5 [3, 11]

21.5 [13, 32.5]

<0.001

  1. aFisher’s exact test, IQR-interquartile range [25%, 75%], rhGH- recombinant human growth hormone. All data are shown per center, except the numbers of patients receiving rhGH, which are shown per nephrologist